Travere Therapeutics Inc. buy klostergang
Start price
01.07.19
/
50%
€19.10
Target price
04.11.21
€33.37
Performance (%)
-35.06%
End price
17.06.21
€12.40
Summary
This prediction ended on 17.06.21 with a price of €12.40. Massive losses of -35.06% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Travere Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -0.552% | 3.281% | 15.052% | 17.017% |
| iShares Nasdaq 100 | -1.415% | 4.535% | 26.243% | 54.337% |
| iShares Nikkei 225® | -0.877% | -1.739% | 4.897% | 4.751% |
| iShares S&P 500 | -0.415% | 3.239% | 23.253% | 46.758% |
Comments by klostergang for this prediction
In the thread Travere Therapeutics Inc. diskutieren
Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und
fortgeschrittener pipeline: